Recruitment for a clinical trial of drug treatment for benign prostatic hyperplasia

Author： Kusek J.W.   Ahrens A.   Burrows P.K.   Clarke H.S.   Foster H.E.   Hanson K.   Jacobs S.C.   Kirkemo A.   O'Berry K.   Pavlik V.N.   for the MTOPS Research Group  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.59, Iss.1, 2002-01, pp. : 63-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatment of Benign Prostatic Hyperplasia and Hospital Admission for BPH-Related Surgery

By Souverein P.C.   Erkens J.A.   de la Rosette J.J.M.C.H.   Leufkens H.G.M.   Herings R.M.C.  

European Urology, Vol. 43, Iss. 5, 2003-05 ,pp. : 528-534

Elsevier

Access to resources Recommend Favorite

Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia

By Boyle P.   Robertson C.   Lowe F.   Roehrborn C.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 533-539

Elsevier

Access to resources Recommend Favorite

Laser treatment of benign prostatic hyperplasia

By Kuntz Rainer  

World Journal of Urology, Vol. 25, Iss. 3, 2007-06 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite

Lasers in the treatment of benign prostatic hyperplasia

By Gerber G.S.  

Urology, Vol. 45, Iss. 2, 1995-02 ,pp. : 193-199

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial 1

By Roehrborn C.G.   for the ALFUS STUDY GROUP  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 953-959

Elsevier

Access to resources Recommend Favorite